BORSELLO, TIZIANA
 Distribuzione geografica
Continente #
EU - Europa 3.992
NA - Nord America 3.558
AS - Asia 1.799
SA - Sud America 168
OC - Oceania 27
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.562
Nazione #
US - Stati Uniti d'America 3.487
GB - Regno Unito 1.295
IT - Italia 837
CN - Cina 796
DE - Germania 749
SG - Singapore 532
SE - Svezia 261
RU - Federazione Russa 194
BR - Brasile 145
IE - Irlanda 144
IN - India 110
FR - Francia 104
DK - Danimarca 81
KR - Corea 81
FI - Finlandia 79
ID - Indonesia 77
NL - Olanda 76
CA - Canada 63
TR - Turchia 50
UA - Ucraina 41
BE - Belgio 36
JP - Giappone 35
HK - Hong Kong 30
CH - Svizzera 20
AT - Austria 19
VN - Vietnam 19
AU - Australia 18
PH - Filippine 17
EU - Europa 13
TW - Taiwan 13
ES - Italia 12
NZ - Nuova Zelanda 9
GR - Grecia 8
NO - Norvegia 8
PK - Pakistan 7
AR - Argentina 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
SC - Seychelles 5
LV - Lettonia 4
MA - Marocco 4
UZ - Uzbekistan 4
VE - Venezuela 4
CL - Cile 3
CU - Cuba 3
HU - Ungheria 3
MX - Messico 3
AL - Albania 2
BD - Bangladesh 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HR - Croazia 2
IL - Israele 2
IQ - Iraq 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MD - Moldavia 2
PE - Perù 2
TH - Thailandia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EC - Ecuador 1
EE - Estonia 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PL - Polonia 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 9.574
Città #
Southend 1.173
Hanover 435
Milan 349
Singapore 345
Chandler 310
Fairfield 306
Seattle 272
Wilmington 190
Ashburn 171
Princeton 167
Houston 166
Council Bluffs 153
Woodbridge 152
Dublin 144
Beijing 137
Santa Clara 132
Dearborn 115
Cambridge 113
Frankfurt am Main 112
Phoenix 100
Ann Arbor 87
Grafing 77
Des Moines 64
Jakarta 59
Nanjing 59
Bengaluru 49
Boardman 45
Guangzhou 37
Shanghai 36
Roxbury 35
Cangzhou 34
Redwood City 34
Fuzhou 31
Rome 28
San Diego 28
Brussels 27
Nanchang 27
Shenyang 26
Helsinki 23
Kent 21
Jinan 20
Silver Spring 20
The Dalles 20
Naples 18
Vienna 18
Berlin 17
Toronto 17
Changsha 16
Istanbul 16
Norwalk 16
Nuremberg 16
Quanzhou 16
Tianjin 16
Fremont 15
Mountain View 14
Redmond 14
Dong Ket 13
Edinburgh 13
Hebei 13
Bitonto 12
Groningen 12
São Paulo 12
Jiaxing 11
Jacksonville 10
New York 10
Padova 10
Seoul 9
Turin 9
Brescia 8
Göttingen 8
Hong Kong 8
Menlo Park 8
Montréal 8
Ottawa 8
Parma 8
Tokyo 8
Xian 8
Andover 7
Düsseldorf 7
Kunming 7
London 7
Los Angeles 7
Medford 7
Piscataway 7
San Francisco 7
Torino 7
Wuhan 7
Bergamo 6
Bühl 6
Chengdu 6
Chicago 6
Munich 6
Ningbo 6
Sakarya 6
Segrate 6
Serra 6
Shenzhen 6
Somerville 6
Taipei 6
Amsterdam 5
Totale 6.491
Nome #
Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy 312
The Parkinson’s Disease-Linked Protein DJ-1 Associates with Cytoplasmic mRNP Granules During Stress and Neurodegeneration 264
Axonal transport in a peripheral diabetic neuropathy model : sex-dimorphic features 250
Common pathways in dementia and diabetic retinopathy : understanding the mechanisms of diabetes-related cognitive decline 243
JNK as an innovative target to tackle rett syndrome 227
Exploring the role of MKK7 in excitotoxicity and cerebral ischemia : a novel pharmacological strategy against brain injury 193
The c-jun N-terminal kinase plays a key role in ocular degenerative changes in a mouse model of Alzheimer disease suggesting a correlation between ocular and brain pathologies 188
Pharmacological c-Jun NH2-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease in Mice 186
C-Jun N-terminal kinase pathway activation in human and experimental traumatic brain injury neuroprotective effects if its inhibition 176
JNK signaling activation in the Ube3a maternal deficient mouse model: Its specific inhibition prevents post-synaptic protein-enriched fraction alterations and cognitive deficits in Angelman Syndrome model 176
Principi di Anatomia Microscopica con cenni di Istologia e Anatomia Macroscopica 175
Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons 171
A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance 171
A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein 169
Intracellular stress signaling pathways activated during human islet preparation and following acute cytokine exposure 168
Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease 167
The Tat-Aβ1-6A2V(D) peptide against AD synaptopathy 166
Adenosine and ADP prevent apoptosis in cultured rat cerebellar granule cells 165
c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo 161
Crosstalk between JNK and SUMO signaling pathways : deSUMOylation is protective against H2O2-induced cell injury 160
Contribution of serine racemase/d-serine pathway to neuronal apoptosis 155
c-Jun N-terminal kinase pathway activation in human and experimental cerebral contusion 151
The Stress c-Jun N-terminal Kinase Signaling Pathway Activation Correlates with Synaptic Pathology and Presents A Sex Bias in P301L Mouse Model of Tauopathy 148
Differential relevance of NF-κB and JNK in the pathophysiology of hemorrhage/resususcitation-induced liver injury after chronic ethanol feeding 146
Evidence of Presynaptic Localization and Function of the c-Jun N-Terminal Kinase 143
Neuronal Localization of SENP Proteins with Super Resolution Microscopy 140
An innovative model for Alzheimer’s disease 136
Excitotoxicity-related endocytosis in cortical neurons 136
JNK3 as Therapeutic Target and Biomarker in Neurodegenerative and Neurodevelopmental Brain Diseases 134
Molecular and Cellular Mechanisms of Synaptopathies 132
Motor coordination and synaptic plasticity deficits are associated with increased cerebellar activity of NADPH oxidase, CAMKII, and PKC at preplaque stage in the TgCRND8 mouse model of Alzheimer's disease 128
An innovative model to study Alzheimer’s disease 123
Gender-genotype interaction lead to an increase of cognitive impairment, locomotor dysfunctions and neurola damage in young and aged female TAU P301L mice model of tauopathy 119
Soluble Aβ oligomer-induced synaptopathy : C-Jun N-terminal kinase's role 118
The cell-permeable Aβ1-6A2VTAT(D) peptide reverts synaptopathy induced by Aβ1-42wt 117
Salivary microRNA profiling dysregulation in autism spectrum disorder: A pilot study 116
An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo 116
JNK signaling provides a novel therapeutic target for Rett syndrome 116
JNK Contributes to Hif-1α Regulation in Hypoxic Neurons 115
Deregulated Local Protein Synthesis in the Brain Synaptosomes of a Mouse Model for Alzheimer's Disease 113
The cell permeable peptide strategy is a promising new tool for the prevention of neurodegeneration 112
Role of glycogen synthase kinase-3β in APP hyperphosphorylation induced by NMDA stimulation in cortical neurons 110
Epidermal RAF prevents allergic skin disease 107
Use of cell-permeable peptides to prevent neuronal degeneration 104
Embryonic purkinje cells grafted on the surface of the adult uninjured rat cerebellum migrate in the host parenchyma and induce sprouting of intact climbing fibres 100
Exposure to kainic acid mimics the effects of axotomy in cerebellar Purkinje cells of the adult rat 97
An N-terminal cleavage fragment of the prion protein binds to specific assemblies of the amyloid-beta peptide and blocks their neurotoxic effects 95
c-Jun N-terminal Kinase regulates soluble Abeta oligomers and cognitive impairment in an AD mouse model 95
A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia 92
Embryonic Purkinje cells grafted on the surface of the cerebellar cortex integrate in the adult unlesioned cerebellum 90
Abnormal cortical lysosomal β-hexosaminidase and β-galactosidase activity at post-synaptic sites during Alzheimer's disease progression 90
Ectopic Purkinje cells in the adult rat: Olivary innervation and different capabilities of migration and development after grafting 88
Regressive modifications of climbing fibres following Purkinje cell degeneration in the cerebellar cortex of the adult rat 88
c-Jun N-terminal kinase 1 (JNK1) modulates oligodendrocyte progenitor cell architecture, proliferation and myelination 87
Neuronal death and neuroprotection: a review 85
Neuroprotective effects of low fat-protein diet in the P301L mouse model of tauopathy 83
Synaptic alterations as a common phase in neurological and neurodevelopmental diseases: JNK is a key mediator in synaptic changes 81
The JNK signalling transduction pathway in the brain 81
C-Jun N-terminal kinase (JNK) and P38 play different roles in age-related Purkinje cell death in murine organotypic culture 81
Kainate-induced endocytosis in retinal amacrine cells 80
Effect of 3D Synthetic Microscaffold Nichoid on the Morphology of Cultured Hippocampal Neurons and Astrocytes 79
Determination of tissue levels of a neuroprotectant drug : the cell permeable JNK inhibitor peptide 78
N-methyl-d-aspartate-triggered neuronal death in organotypic hippocampal cultures is endocytic, autophagic and mediated by the c-Jun N-terminal kinase pathway 78
Colocalization and Interaction Study of Neuronal JNK3, JIP1, and β-Arrestin2 Together with PSD95 78
Specific JNK inhibition by D-JNKI1 protects Purkinje cells from cell death in Lurcher mutant mouse 77
Granule neuron DNA damage following deafferentation in adult rats cerebellar cortex: a lesion model 77
Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation 76
Targeting the JNK pathway as a therapeutic protective strategy for nervous system diseases 76
The neurodegeneration in Alzheimer disease and the prion protein 76
JNK3 as a therapeutic target for neurodegenerative diseases 74
JNK plays a key role in tau hyperphosphorylation in Alzheimer's disease models 73
c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons 73
Phosphorylation-dependent dimerization and subcellular localization of islet-brain 1/c-Jun N-terminal kinase-interacting protein 1 72
Super-resolution study of PIAS SUMO E3-ligases in hippocampal and cortical neurons 72
The TAT-JNK inhibitor peptide interferes with beta amyloid protein stability 70
Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury 69
JNK regulates APP cleavage and degradation in a model of Alzheimer's disease 67
JNK signalling: a possible target to prevent neurodegeneration 65
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease 64
A peptide inhibitor of C-jun N-terminal kinase modulates hepatic damage and the inflammatory response after hemorrhagic shock and resuscitation 60
Inhibition of c-jun n-terminal kinase after hemorrhage but before resuscitation mitigates hepatic damage and inflammatory response in male rats 60
JNK pathway as therapeutic target to prevent degeneration in the central nervous system 54
Recombinant human TNF-binding protein-1 (rhTBP-1) treatment delays both symptoms progression and motor neuron loss in the wobbler mouse 53
Synaptic Proteins as Fluid Biomarkers in Alzheimer's Disease: A Systematic Review and Meta-Analysis 47
Ultrastructure of retinal ganglion cell death after axotomy in chick embryos 46
A peptide inhibitor of C-JUN N-terminal kinase modulates hepatic damage and the inflammatory response after hemorrhagic shock and resuscitation 42
Metodo diagnostico 33
Inflammation and depression: A study protocol to dissect pathogenetic mechanisms in the onset, comorbidity and treatment response 31
Peptidomimetics design and characterization: Bridging experimental and computer-based approaches 31
JNK Activation Correlates with Cognitive Impairment and Alteration of the Post-Synaptic Element in the 5xFAD AD Mouse Model 26
Medoto Diagnostico 26
JNK3 INHIBITORY PEPTIDES 25
Totale 10.264
Categoria #
all - tutte 31.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.013


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020110 0 0 0 0 0 0 0 0 0 0 66 44
2020/2021880 49 86 43 46 102 82 40 74 155 78 61 64
2021/20221.357 58 68 33 65 48 38 385 96 94 133 100 239
2022/20231.356 131 93 125 149 156 257 50 86 202 19 49 39
2023/2024865 33 69 49 112 166 40 34 57 23 53 93 136
2024/20251.780 102 202 66 213 281 115 144 281 131 202 43 0
Totale 10.264